Makes perfect sense to partner for PC. This will be a significant commitment, as there is a lot of optimizing to be done (earlier dosing, increased dosing, longer dosing and enhanced antigen pep mix along with checkpoint blockade, with various options including anti-PD1/PDL1, VISTA, LAG3, CTLA4 among others). I think this immuno/chemo combo is really the best hope I have seen that can make a serious dent in PC. The CR with Folfirinox is a very good sign though not confirmatory of activity just yet.
News 
Market Data 
Discover 
